Mainz Biomed N.V. (MYNZ)
NASDAQ: MYNZ · Real-Time Price · USD
1.200
-0.030 (-2.44%)
At close: Dec 19, 2025, 4:00 PM EST
1.240
+0.040 (3.33%)
After-hours: Dec 19, 2025, 7:09 PM EST
Mainz Biomed Market Cap
Mainz Biomed has a market cap or net worth of $10.3 million as of December 19, 2025. Its market cap has decreased by -3.19% in one year.
Market Cap
10.30M
Enterprise Value
11.48M
1-Year Change
-3.19%
Ranking
Category
Stock Price
$1.20
Market Cap Chart
Since the IPO on November 5, 2021, Mainz Biomed's market cap has decreased from $58.55M to $10.30M, a decrease of -82.41%. That is a compound annual growth rate of -34.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 19, 2025 | 10.30M | -29.22% |
| Dec 31, 2024 | 14.55M | -38.37% |
| Dec 29, 2023 | 23.62M | -77.05% |
| Dec 30, 2022 | 102.90M | -17.54% |
| Dec 31, 2021 | 124.78M | 113.12% |
| Nov 5, 2021 | 58.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 951.80B |
| Johnson & Johnson | 505.54B |
| AbbVie | 397.22B |
| UnitedHealth Group | 297.37B |
| AstraZeneca | 281.50B |
| Novartis AG | 260.63B |
| Merck & Co. | 248.92B |
| Abbott Laboratories | 221.09B |